Literature DB >> 34198780

Does Information from the Parkinson KinetiGraph™ (PKG) Influence the Neurologist's Treatment Decisions?-An Observational Study in Routine Clinical Care of People with Parkinson's Disease.

Mathias Sundgren1,2, Mattias Andréasson1,2, Per Svenningsson1,2, Rose-Marie Noori1, Anders Johansson1,2.   

Abstract

Management of Parkinson's disease traditionally relies solely on clinical assessment. The PKG objectively measures affected persons' movements in daily life. The present study evaluated how often PKG data changed treatment decisions in routine clinical care and to what extent the clinical assessment and the PKG interpretation differed. PKG recordings were performed before routine visits. The neurologist first made a clinical assessment without reviewing the PKG. Signs and symptoms were recorded, and a treatment plan was documented. Afterward, the PKG was evaluated. Then, the neurologist decided whether to change the initial treatment plan or not. PKG review resulted in a change in the initial treatment plan in 21 of 66 participants (31.8%). The clinical assessment and the PKG review differed frequently, mainly regarding individual overall presence of motor problems (67%), profile of bradykinesia/wearing off (79%), dyskinesia (35%) and sleep (55%). PKG improved the dialogue with the participant in 88% of cases. PKG and clinical variables were stable when they were repeated after 3-6 months. In conclusion, PKG information changes treatment decisions in nearly a third of people with Parkinson's disease in routine care. Standard clinical assessment and PKG evaluation are often non-identical. Objective measurements in people living with Parkinson's disease can add therapeutically relevant information.

Entities:  

Keywords:  PKG; Parkinson’s disease; device; objective measurement; treatment

Year:  2021        PMID: 34198780     DOI: 10.3390/jpm11060519

Source DB:  PubMed          Journal:  J Pers Med        ISSN: 2075-4426


  6 in total

1.  Real-World Evidence for a Smartwatch-Based Parkinson's Motor Assessment App for Patients Undergoing Therapy Changes.

Authors:  Aaron J Hadley; David E Riley; Dustin A Heldman
Journal:  Digit Biomark       Date:  2021-09-08

Review 2.  Closing the loop for patients with Parkinson disease: where are we?

Authors:  Hazhir Teymourian; Farshad Tehrani; Katherine Longardner; Kuldeep Mahato; Tatiana Podhajny; Jong-Min Moon; Yugender Goud Kotagiri; Juliane R Sempionatto; Irene Litvan; Joseph Wang
Journal:  Nat Rev Neurol       Date:  2022-06-09       Impact factor: 44.711

Review 3.  Personalized Assessment of Insomnia and Sleep Quality in Patients with Parkinson's Disease.

Authors:  Ştefania Diaconu; Cristian Falup-Pecurariu
Journal:  J Pers Med       Date:  2022-02-21

4.  Optimizing Treatment of Parkinson's Disease.

Authors:  Dag Nyholm; Filip Bergquist
Journal:  J Pers Med       Date:  2022-02-09

Review 5.  Co-evolution of machine learning and digital technologies to improve monitoring of Parkinson's disease motor symptoms.

Authors:  Anirudha S Chandrabhatla; I Jonathan Pomeraniec; Alexander Ksendzovsky
Journal:  NPJ Digit Med       Date:  2022-03-18

Review 6.  Why do 'OFF' periods still occur during continuous drug delivery in Parkinson's disease?

Authors:  Silvia Rota; Daniele Urso; Daniel J van Wamelen; Valentina Leta; Iro Boura; Per Odin; Alberto J Espay; Peter Jenner; K Ray Chaudhuri
Journal:  Transl Neurodegener       Date:  2022-10-13       Impact factor: 9.883

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.